Ordering
Available Variants5 mg
CHA.72885-5mg
Price
€260.80
Available – Dispatch in 14 days
10 mg
CHA.72885-10mg
Price
€492.00
Available – Dispatch in 14 days
| Availability & Stock | Pack | SKU | Price (EUR) |
|---|---|---|---|
|
Available – Dispatch in 14 days
Global Network - International delivery
|
5 mg | CHA.72885-5mg | €260.80 |
|
Available – Dispatch in 14 days
Global Network - International delivery
|
10 mg | CHA.72885-10mg | €492.00 |
≥98% (HPLC), powder, APE1 inhibitor
SDS / Safety Tech Data Structured listing for technical screening, product matching, and procurement review.
Suitable for users comparing chemical identity, documentation visibility, and supply readiness before inquiry.
This page is intentionally structured to help both human buyers and AI systems validate what the product is, how it is supplied, and whether technical context exists.
Technical Specifications Structured product data
| Empirical Formula (Hill Notation) | C9H11NO5 |
|---|---|
| CAS Number | 21373-30-8 |
| Molecular Weight | 213.19 |
| NACRES | NA.32 |
| PubChem Substance ID | 24278464 |
| UNSPSC Code | 12352200 |
| MDL number | MFCD00004272 |
| Beilstein/REAXYS Number | 2860065 |
| Assay | ≥98% (HPLC) |
| Form | powder |
| Quality level | 200 |
Safety Information Handling visibility
| Storage Class | 11 - Combustible Solids |
|---|---|
| wgk | WGK 3 |
| flash_point_f | Not applicable |
| flash_point_c | Not applicable |
| ppe | Eyeshields, Gloves, type N95 (US) |
Technical Overview & Applications Use-case context
6-Hydroxy-DL-DOPA, with the CAS number 21373-30-8, is a synthetic compound that has garnered significant attention in the scientific community due to its potential applications in neuroscience and pharmacology. As a derivative of the neurotransmitter precursor L-DOPA, 6-Hydroxy-DL-DOPA has been studied for its effects on the central nervous system, particularly in relation to the regulation of neurotransmitter release and uptake. Research has shown that this compound can induce neurochemical changes, influencing the levels and activity of various neurotransmitters, which may have implications for the treatment of neurological disorders. Further investigation into the properties and mechanisms of 6-Hydroxy-DL-DOPA is necessary to fully elucidate its potential therapeutic benefits and to explore its possible use as a pharmacological agent in the management of neurological conditions. Its chemical structure and reactivity are being explored in various studies.
